Hydroxyzine Dosing for Anxiety
For adults with generalized anxiety disorder, hydroxyzine should be dosed at 50-100 mg four times daily (QID), starting at the lower end of this range and titrating based on response and tolerability. 1
Adult Dosing
According to FDA labeling, the standard dosing for symptomatic relief of anxiety and tension is:
- Adults: 50-100 mg QID 1
- Start at 50 mg QID and adjust based on patient response
- The most studied dose in clinical trials is 50 mg/day (typically divided), which demonstrated efficacy from the first week of treatment 2, 3
Pediatric Dosing
For children with anxiety:
- Under 6 years: 50 mg daily in divided doses
- Over 6 years: 50-100 mg daily in divided doses 1
Note: The 2020 AACAP guideline for pediatric anxiety disorders does not specifically recommend hydroxyzine, instead prioritizing SSRIs and CBT as first-line treatments 4. Hydroxyzine should be considered a second-line or adjunctive option in children.
Clinical Evidence Supporting Dosing
Multiple controlled trials confirm that 50 mg/day is effective for GAD:
- Superiority over placebo on all anxiety measures from week 1 2
- Maintained efficacy throughout 4 weeks without rebound anxiety upon discontinuation 3
- A 3-month trial confirmed sustained efficacy and safety at 50 mg/day 5
Higher doses (up to 400 mg/day total) are FDA-approved but not necessarily more effective, and higher doses increase adverse effects, particularly sedation.
Critical Safety Considerations
QT Prolongation Risk: Hydroxyzine can cause QT prolongation and Torsades de Pointes 1. Use with extreme caution or avoid in patients with:
- Congenital long QT syndrome or family history
- Recent myocardial infarction
- Uncompensated heart failure
- Electrolyte imbalances
- Concomitant use of other QT-prolonging drugs (citalopram, fluoxetine, azithromycin, methadone, antipsychotics) 1
CNS Depression: Hydroxyzine potentiates CNS depressants 1. When used with narcotics, barbiturates, or alcohol, reduce the dose of the CNS depressant.
Elderly Patients: Start at the low end of the dosing range due to increased risk of confusion, over-sedation, and decreased renal function 1. Consider 25 mg TID initially.
Common Pitfalls
- Transient drowsiness occurs in approximately 28% of patients but typically resolves after the first week 3
- Warn patients about driving and operating machinery during initial treatment
- Do not abruptly discontinue after prolonged use, though hydroxyzine does not cause the same withdrawal syndrome as benzodiazepines
- AGEP (Acute Generalized Exanthematous Pustulosis) is a rare but serious skin reaction—discontinue immediately if rash develops 1
Practical Dosing Algorithm
- Start: 50 mg QID (or 25 mg TID in elderly/frail patients)
- Assess response at 1 week—efficacy should be evident by this time 2
- Titrate up to 100 mg QID if inadequate response and well-tolerated
- Maximum: 400 mg/day total, though most patients respond to 200 mg/day or less
- Monitor: QT interval if risk factors present, sedation level, and anxiety symptoms
Hydroxyzine represents an alternative to benzodiazepines with comparable efficacy but without dependency risk 5, though SSRIs remain first-line for long-term GAD management in most guidelines.